These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15059270)

  • 21. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities.
    Ioan-Facsinay A; el-Bannoudi H; Scherer HU; van der Woude D; Ménard HA; Lora M; Trouw LA; Huizinga TW; Toes RE
    Ann Rheum Dis; 2011 Jan; 70(1):188-93. PubMed ID: 20736390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to citrullinated proteins in arthritis: pathology and promise.
    Klareskog L; Widhe M; Hermansson M; Rönnelid J
    Curr Opin Rheumatol; 2008 May; 20(3):300-5. PubMed ID: 18388522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-cyclic citrullinated peptide versus anti-Sa antibodies in diagnosis of rheumatoid arthritis in an outpatient clinic for connective tissue disease and spondyloarthritis.
    López-Longo FJ; Rodríguez-Mahou M; Sánchez-Ramón S; Estecha A; Balsera M; Plaza R; Fernández-Cruz E; Pérez LC
    J Rheumatol; 2006 Aug; 33(8):1476-81. PubMed ID: 16881106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders.
    Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
    J Rheumatol; 2009 Dec; 36(12):2670-4. PubMed ID: 19884278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
    van Venrooij WJ; van Beers JJ; Pruijn GJ
    Ann N Y Acad Sci; 2008 Nov; 1143():268-85. PubMed ID: 19076355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis.
    Bokarewa M; Lindblad S; Bokarew D; Tarkowski A
    Arthritis Res Ther; 2005; 7(2):R349-58. PubMed ID: 15743483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis.
    Hill JA; Al-Bishri J; Gladman DD; Cairns E; Bell DA
    J Rheumatol; 2006 Nov; 33(11):2115-9. PubMed ID: 16924693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
    Svärd A; Kastbom A; Söderlin MK; Reckner-Olsson Å; Skogh T
    J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis.
    Pruijn GJ; Wiik A; van Venrooij WJ
    Arthritis Res Ther; 2010; 12(1):203. PubMed ID: 20236483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of citrullinated eukaryotic translation initiation factor 4G1 as novel autoantigen in rheumatoid arthritis.
    Okazaki Y; Suzuki A; Sawada T; Ohtake-Yamanaka M; Inoue T; Hasebe T; Yamada R; Yamamoto K
    Biochem Biophys Res Commun; 2006 Mar; 341(1):94-100. PubMed ID: 16412378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of anti-cyclic citrullinated peptide antibodies in predicting rheumatoid arthritis.
    Rexhepi S; Rexhepi M; Sahatçiu-Meka V; Tafaj A; Izairi R; Rexhepi B
    Reumatizam; 2011; 58(1):12-4. PubMed ID: 21751570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Predictors of response to biologic therapies in rheumatoid arthritis].
    Chaves Chaparro LM; Salvatierra Ossorio J; Raya Álvarez E
    Reumatol Clin; 2011; 7(2):141-4. PubMed ID: 21794800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Novel autoantibodies for the diagnosis of rheumatoid arthritis].
    Steiner G; Smolen JS
    Z Rheumatol; 2002 Dec; 61(6):667-73. PubMed ID: 12491130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
    Koivula MK; Aman S; Karjalainen A; Hakala M; Risteli J
    Ann Rheum Dis; 2005 Oct; 64(10):1443-50. PubMed ID: 16162901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor.
    Vander Cruyssen B; Peene I; Cantaert T; Hoffman IE; De Rycke L; Veys EM; De Keyser F
    Autoimmun Rev; 2005 Sep; 4(7):468-74. PubMed ID: 16137613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
    N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic and prognostic significance of antibodies against citrullinated peptides].
    Schulze-Koops H; Manger B
    Dtsch Med Wochenschr; 2006 Feb; 131(6):269-71. PubMed ID: 16463231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Citrullinated peptide and its relevance to rheumatoid arthritis: an update.
    Luban S; Li ZG
    Int J Rheum Dis; 2010 Oct; 13(4):284-7. PubMed ID: 21199462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibodies against citrullinated proteins--a breakthrough in rheumatologic diagnostics].
    Rönnelid J; Klareskog L; Skogh T; Svensson B
    Lakartidningen; 2004 Dec; 101(50):4092-6. PubMed ID: 15631262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.